CALADRIUS BIOSCIENCES, INC. (22)
Browse by Contract Category
Contracts
-
Description of Capital Stock
(Filed With SEC on February 25, 2021)
-
Placement Agent Agreement dated as of February 11, 2021, by and between the Company and H.C. Wainwright & Co., LLC
(Filed With SEC on February 16, 2021)
-
Offer Letter Amendment dated October 6, 2015, to Employment Agreement dated June 28, 2011 and effective October 6, 2015, by and between the Company and Joseph Talamo
(Filed With SEC on March 14, 2019)
-
Form of Institutional Additional Securities Purchase Agreement
(Filed With SEC on February 16, 2021)
-
Form of Institutional Securities Purchase Agreement
(Filed With SEC on February 16, 2021)
-
Form of Warrant
(Filed With SEC on February 16, 2021)
-
Form of Registration Rights Agreement, dated January 21, 2021
(Filed With SEC on January 25, 2021)
-
Form of Securities Purchase Agreement, dated January 21, 2021
(Filed With SEC on January 25, 2021)
-
Form of Warrant
(Filed With SEC on January 25, 2021)
-
Form of Warrant
(Filed With SEC on July 10, 2020)
-
Form of Purchase Agreement
(Filed With SEC on July 10, 2020)
-
Form of Registration Rights Agreement
(Filed With SEC on July 10, 2020)
-
Placement Agent Agreement dated as of November 5, 2019, as subsequently amended on each of March 11, 2020, April 23, 2020 and May 25, 2020, by and between the Company and H.C....
(Filed With SEC on May 26, 2020)
-
Form of Warrant
(Filed With SEC on May 26, 2020)
-
Form of Purchase Agreement
(Filed With SEC on May 26, 2020)
-
Placement Agent Agreement dated as of November 5, 2019, as subsequently amended, by and between the Company and H.C. Wainwright & Co., LLC
(Filed With SEC on April 24, 2020)
-
Form of Purchase Agreement
(Filed With SEC on April 24, 2020)
-
Form of Warrant
(Filed With SEC on April 24, 2020)
-
Description of Capital Stock
(Filed With SEC on March 5, 2020)
-
Purchase Agreement, dated March 13, 2019, by and between Caladrius Biosciences, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on March 14, 2019)
-
Registration Rights Agreement, dated March 13, 2019 by and between Caladrius Biosciences, Inc. and Lincoln Park Capital Fund, LLC
(Filed With SEC on March 14, 2019)
-
Director Compensation Policy (filed as Exhibit 10.1 to the Companys Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on March 22, 2018 and...
(Filed With SEC on March 14, 2019)
